RedHill Biopharma
Tel Aviv
About RedHill Biopharma
RedHill Biopharma specializes in the field of gastrointestinal and infectious diseases, constituting its primary areas of focus within the realm of specialty biopharmaceuticals. It focuses on advancing gastrointestinal and infectious diseases management through innovation, dedication, and a collective mindset of delivering on its promises.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $282.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:RDHL
- Website: redhillbio.com
- Phone: +972 3-541-3131
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/redhill-biopharma-127959 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.